Log in to your Inderes Free account to see all free content on this page.
Modus Therapeutics Holding
0.29 SEK
+2.85 %
Less than 1K followers
MODTX
First North Stockholm
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data
Valuation
Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Modus Therapeutics Holding
P/B
Median 2021-2025
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|
| Share price (SEK) | - | 1.50 | 1.10 | 0.68 | 0.71 | 0.30 |
| Shares | 40.8 | 40.8 | 40.8 | 57.4 | 91.2 | 121.6 |
| Market cap | - | 61.2 | 44.9 | 39.3 | 64.9 | 37.0 |
| Enterprise value | - | 40.5 | - | - | - | - |
| EV/S | - | - | - | - | - | - |
| EV/EBITDA | - | neg. | - | - | - | - |
| EV/EBIT | - | neg. | - | - | - | - |
| P/E | - | neg. | neg. | neg. | neg. | neg. |
| P/B | - | 3.89 | -17.34 | 2.22 | 30.31 | 4.08 |
| P/S | - | - | - | - | - | - |
| Dividend yield | - | 0.0 % | 0.0 % | 0.0 % | 0.0 % | 0.0 % |
| Equity ratio | 93.4 % | 74.2 % | -23.0 % | 88.2 % | 43.9 % | 71.5 % |
| Gearing ratio | - | - | -444.0 % | - | - | - |
Login required
This content is only available for logged in users